Question: How do you see the future of cancer diagnostics?

IMO this is how I view it but what is the perception of the industry?

The ultimate patient's questions about cancer.
Do I have it?
What type is it?
Where is it located?
Can it be removed?

Is it gone yet?
Has it returned?

Healthcare (in or out of the hospital) follows a mode of operation. They start with a general assesment and narrow in on the root cause. Recaf may be used first to screen the general population to test for the presence of any type cancer.

Keep in mind that 1 in 3 people will develope cancer in a lifetime. That also means that 2 in 3 will not get cancer. This negative group in the US. population is equal to about 220 million people assuming our population is 360 million. This same assumption means that 1 billion chinese will be effected but 2 billion will not.

It would be very expensive for the insurance companies to test each person with a pallet of say 20 types of biomarkers specific to only one type of cancer.

I see an industry that will start with a Recaf to separate Cancerous persons from non cancerous persons. Those with cancer will then be exposed to a pallet of cancer specific biomarkers and or scanned to internally locate it.

This multi pallet would most likely contain many biomarkers such as Recaf, EPCA-?, CEA and other highly sensitive markers we have not even heard of yet.

The scan will be "X" and will need to show where it is, if it is operable or if it has been reduced in size. Ultimately the scan will assist in the destruction of the cancer via some type of delivery device.

The bottom line is the only markers that will not be used are those that cannot keep pace with the new ones coming out. I would assume that the Area under the curve (AUC) results will determine this answer. As it stands now, Biocurex has a tremendous front line of tools.